VC  Fletcher Spaght Ventures

http://www.fletcherspaght.com





     Office Locations:

222 Berkeley Street
20th Floor
Boston, MA 02116-3761
Phone: 617-247-6700
Fax: 617-247-7757

 

Stages:

  • Early


 

Industries:

  • Communications & Networking
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Software & Internet

  •  

    Description:

    Established in 2001, Fletcher Spaght Ventures (FSV) is a venture capital fund investing in emerging growth healthcare and high technology companies, as well as mature corporations. Established by Fletcher Spaght, Inc. (FSI), a strategy consulting firm, FSV invests in companies with familiarity/experience with FSI, promising business potential, and financing led by top-tier venture capital firms. FSV does not intend to lead deals, but will collaborate with and support the lead investors. The firm focuses on companies in the areas of information technology (IT) and IT services, Internet, software, telecommunications, medical devices, healthcare informatics, biotechnology and healthcare services.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Guy Fish MD Senior Vice President
    John Fletcher Managing Partner
    Linda Tufts General Partner
    Lisa Granick Senior Vice President
    Molly Hoult Senior Vice President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/12/2017


      Cheetah Medical


      WA


      $11,760,000


      Series C


     

    Portfolio companies include:


      BIOCIUS Life Sciences
        web link


      Bioscan
        web link


      BioTrove
        web link


      Cadent
        web link


      CardioFocus
        web link


      Cayenne Medical
        web link


      Cheetah Medical
        web link


      HistoSonics
        web link


      HTG Molecular Diagnostics
        web link


      Ikano Therapeutics
        web link


      Interactive Supercomputing
        web link


      Juventas Therapeutics
        web link


      Metabolon
        web link


      PhaseBio Pharmaceuticals
        web link


      Proteus Biomedical
        web link


      Quick Study Radiology
        web link


      SironRX Therapeutics
        web link


      Soleo Communications
        web link


      Soteira
        web link


      SurgiQuest
        web link


      Swift Biosciences
        web link


      TSD Rental
        web link


     

    Recent News: